Tumor News and Research

RSS

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer.

17 May 2024

Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

17 May 2024

New CT-derived functional imaging software enhances lung diagnosis without contrast dye

For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes to life-threatening lung issues such as pulmonary embolism.

17 May 2024

POSTECH and ImmunoBiome make significant breakthrough in the fight against cancer

A team of POSTECH and ImmunoBiome has made a significant breakthrough in the fight against cancer. Their research, published in the May issue of Nature Immunology (Volume 25, pages790–801,2024), explores a dietary-derived bacterial strain, IMB001.

17 May 2024

ANU researchers develop new AI tool for rapid, accurate brain tumor classification

A new AI tool to more quickly and accurately classify brain tumors has been developed by researchers at The Australian National University (ANU).

17 May 2024

Study reveals no survival benefit from systemic therapy in very advanced solid tumors

Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published today in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer Center and Yale Cancer Center.

17 May 2024

Liquid biopsy biomarker predicts melanoma therapy response

If black skin cancer (melanoma) spreads, there are various therapies that can be used. However, there is still insufficient research into who responds to which therapy and whether resistance may develop over time.

16 May 2024

Perioperative immunotherapy improves event-free survival in patients with resectable NSCLC

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer(NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.

16 May 2024

Unveiling the role of neutrophils in lung cancer progression

Lung cancer remains a leading global health concern, responsible for the highest number of cancer-related deaths worldwide.

16 May 2024

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Acute liver failure (ALF) is a life-threatening clinical problem with limited treatment options. Administration of human umbilical cord mesenchymal stem cells (hUC-MSCs) may be a promising approach for ALF.

16 May 2024

New study finds Sfrp1 as a potential therapeutic target in cancer treatment

Cancer is a leading cause of death globally. One of the primary reasons why cancer is such a deadly disease is the ability of cancer cells to become drug-resistant.

15 May 2024

Menthol-derived molecules: promising candidates for anti-inflammatory and anti-obesity therapy

Modified derivatives of natural products have led to significant therapeutic advances and commercial success in recent times.

15 May 2024

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene have been linked to different diseases.

15 May 2024

New PET imaging biomarker Gal-1 predicts tumor responses to immunotherapy

The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.

15 May 2024

How AI is set to transform patient outcomes and surgical practices

Using artificial intelligence (AI) in surgery.

15 May 2024

Streamlining immune sensing and signaling dynamics research with INTEGRA Biosciences liquid handling tools

Immunologists in the Immune Sensing and Signaling Dynamics Group | ImmunoHUB at Instituto de Investigação e Inovação em Saúde (i3S) in Porto, Portugal, are using INTEGRA Biosciences laboratory tools to help further our understanding of the human immune system.

From INTEGRA Biosciences 15 May 2024

Study proposes a novel therapeutic avenue for tackling EHF-induced cholangiocarcinogenesis

This study is led by Dr. Yiming Luo (Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) and Professor. Huifang Liang (Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology).

14 May 2024

Research unveils the dual subdomain structure of the centromere

Researchers from the Kops group in collaboration with researchers from the University of Edinburgh, made a surprising new discovery in the structure of the centromere, a structure that is involved in ensuring that chromosomes are segregated properly when a cell divides.

14 May 2024

Exploring how intense ultrasound can release biological indicators of disease

Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, cannot be learned from imaging and requires invasive and damaging biopsies.

14 May 2024

Curcuminoid compounds show promise against COVID-19 in neuronal cells

The effects of curcumin and curcuminoids on a human neuroblastoma cell line (SH-SY5Y) infected with SARS-CoV-2.

14 May 2024

1
2
3
4
...
1172
Next

Tumor News and Research

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

New CT-derived functional imaging software enhances lung diagnosis without contrast dye

POSTECH and ImmunoBiome make significant breakthrough in the fight against cancer

ANU researchers develop new AI tool for rapid, accurate brain tumor classification

Study reveals no survival benefit from systemic therapy in very advanced solid tumors

Liquid biopsy biomarker predicts melanoma therapy response

Perioperative immunotherapy improves event-free survival in patients with resectable NSCLC

Unveiling the role of neutrophils in lung cancer progression

Mechanistic insights into the role of huc-mscs in treating acute liver failure

New study finds Sfrp1 as a potential therapeutic target in cancer treatment

Menthol-derived molecules: promising candidates for anti-inflammatory and anti-obesity therapy

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

New PET imaging biomarker Gal-1 predicts tumor responses to immunotherapy

How AI is set to transform patient outcomes and surgical practices

Streamlining immune sensing and signaling dynamics research with INTEGRA Biosciences liquid handling tools

Study proposes a novel therapeutic avenue for tackling EHF-induced cholangiocarcinogenesis

Research unveils the dual subdomain structure of the centromere

Exploring how intense ultrasound can release biological indicators of disease

Curcuminoid compounds show promise against COVID-19 in neuronal cells

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News